Reconstitution Solution 30mL

In stock
Lot: OR-SLBAC30-526-B3
Grade: Laboratory
Tested pH: 6.2
Vial Size: 30ml
Tested: Endotoxins, Heavy Metals, Microbials
USA Made: cGMP / ISO Aligned
UPS Shipping: Insurance Included
Sterile Solution with 0.9% Benzyl Alcohol
Regular price $19.99 USD
In stock
Ships Within 1 Business Day

Purchase Limit: 2 Units Per Order

    Due to exceptionally high demand, this product is currently restricted to a maximum of 2 units per order. This ensures broader access for all research clients while we continue to scale supply.

    Research Use Only

    This product is limited to in vitro testing and laboratory experimentation and is not for human or animal use or consumption of any kind. Handling and use are restricted to qualified and licensed professionals only.

    30mL Reconstitution Solution (LIMITED TO 2 UNITS PER ORDER)

    Formulated for research and laboratory use, this sterile water is designed for the accurate reconstitution of lyophilized compounds in controlled, sterile environments.

    Composition:

    • 30mL Sterile Water
    • Tested & Confirmed Preserved with 0.9% Benzyl Alcohol
    • Tested for Endotoxins, Heavy Metals, Microbial Contamination
    • Tested pH: 6.2

    For non-clinical, laboratory-based applications only.

    • Store at controlled room temperature (68°F to 77°F).
    • Do not refrigerate or freeze.
    • Once opened, discard within 28 days.
    • Discard if the solution becomes discolored or cloudy.

    This product is limited to in vitro testing and laboratory experimentation and is not intended for human or animal use or consumption under any circumstances. Handling and use are restricted to qualified or licensed professionals only.

    We do not sell syringes, nor do we provide instructions on mixing, dosing, or any research protocol

    This product is not FDA approved and is not classified as a drug, food, or cosmetic. It may not be represented, marketed, or used as such.

    All orders placed through OROS Research are shipped via UPS (free 2-day shipping on orders over $150), and includes full insurance in the event your package is lost, stolen, or damaged in transit.

    To help ensure product integrity during transit, all research materials are packaged in protective boxes that shield vials from direct sunlight and temperature fluctuations.

    Rated Excellent on Trustpilot
    Read our reviews

    Comprehensive Reconstitution Solution Quality Verification

    Every OROS Reconstitution Solution batch is verified across six critical quality attributes—including benzyl alcohol content, pH, endotoxins, microbial contamination, heavy metals, and multi-vial variance—supporting analytical integrity, consistency, and transparency. This testing framework helps confirm that our sterile benzyl alcohol-preserved water meets its labeled 0.9% benzyl alcohol claim and is appropriate for reconstitution of lyophilized materials in a research setting.

    Quality Control Focus: Reconstitution Solution quality depends on more than appearance alone. Benzyl alcohol verification helps confirm preservative content, pH testing helps verify solution consistency, and endotoxin, microbial, heavy metal, and multi-vial variance testing provide additional insight into cleanliness, uniformity, and batch-level control.

    Benzyl Alcohol Content

    Verified

    Confirms the presence of benzyl alcohol and verifies that the batch meets its labeled 0.9% preservative claim for benzyl alcohol-preserved sterile water.

    pH

    Verified

    Measures the acidity or alkalinity of the solution to help confirm batch consistency, formulation control, and suitability for research reconstitution workflows.

    Endotoxins

    Passed

    Screens for bacterial endotoxins, which can be present even when a solution appears clear. This helps support cleanliness and quality control for research reconstitution workflows.

    Microbial Contamination

    Passed

    Tests for unwanted microbial presence to help confirm that the finished solution meets microbiological quality expectations and is produced under controlled conditions.

    Heavy Metals

    Passed

    Screens for elemental impurities such as lead, arsenic, cadmium, and mercury to support contaminant control and overall material quality.

    Multi-Vial Variance

    Passed

    Evaluates multiple vials within the same lot to help confirm consistency across the batch, including preservative content, pH, and finished product uniformity.

    5-Amino-1MQ 50mg
    0 Records
    Product: 5-Amino-1MQ 50mg
    Current Lot
    Volume / Content
    50.88mg
    Lot Number
    OR-LP5A150-526-B1
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    AOD-9064
    0 Records
    Product: AOD-9604 5mg
    Volume / Content
    7.48mg
    Lot Number
    1135493 - Batch 1
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    January 9th 2026
    Purchase Start
    January 11th 2026
    Purchase End
    March 24th 2026
    Product: AOD-9604 5mg
    Volume / Content
    5.21mg
    Lot Number
    OR-LPAOD5-326-B2
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 9th 2026
    Purchase End
    May 14th 2026
    Product: AOD-9604 5mg
    Current Lot
    Volume / Content
    5.06mg
    Lot Number
    OR-LPAOD5-326-B3
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    June 3rd 2026
    Purchase Start
    June 6th 2026
    Purchase End
    Present
    ARA-290
    0 Records
    Product: ARA-290 32mg
    Current Lot
    Volume / Content
    32.89mg
    Lot Number
    OR-LPARA32-526-B1
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    June 3rd 2026
    Purchase Start
    June 6th 2026
    Purchase End
    Present
    AURA
    0 Records
    Volume / Content
    100mg
    Lot Number
    938536 - Batch 1
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    November 18th 2025
    Purchase Start
    November 18th 2025
    Purchase End
    Present
    BPC-157
    0 Records
    Product: BPC-157 5mg
    Volume / Content
    5.07mg
    Lot Number
    395247 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    September 23rd 2025
    Product: BPC-157 5mg
    Volume / Content
    6.13mg
    Lot Number
    413358 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    September 23rd 2025
    Purchase Start
    September 23rd 2025
    Purchase End
    November 7th 2025
    Product: BPC-157 5mg
    Volume / Content
    6.84mg
    Lot Number
    835571 - Batch 3
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    November 28th 2025
    Purchase Start
    November 28th 2025
    Purchase End
    January 19th 2026
    Product: BPC-157 10mg
    Volume / Content
    14.52mg
    Lot Number
    863923 - Batch 1
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    December 13th 2025
    Purchase Start
    December 13th 2025
    Purchase End
    January 28th 2026
    Product: BPC-157 5mg
    Volume / Content
    5.59mg
    Lot Number
    1323471 - Batch 4
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 3rd 2026
    Purchase Start
    February 4th 2026
    Purchase End
    May 16th 2026
    Product: BPC-157 10mg
    Volume / Content
    11.16mg
    Lot Number
    1349811 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 3rd 2026
    Purchase Start
    February 4th 2026
    Purchase End
    March 25th 2026
    Product: BPC-157 10mg
    Current Lot
    Volume / Content
    10.16mg
    Lot Number
    OR-LPBPC10-326-B5
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    Present
    Product: BPC-157 5mg
    Current Lot
    Volume / Content
    5.02mg
    Lot Number
    OR-LPBPC5-526-B5
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    BPC-157 Capsules
    0 Records
    Volume / Content
    500mcg
    Lot Number
    73956 - Batch 1
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    October 27th 2025
    Purchase Start
    November 6th 2025
    Purchase End
    April 16th 2026
    Volume / Content
    536.59
    Lot Number
    OR-CBPC500-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Cartalax
    0 Records
    Product: Cartalax 20mg
    Current Lot
    Volume / Content
    19.30mg
    Lot Number
    OR-CTX20-326 - Batch 1
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    March 27th 2026
    Purchase Start
    March 27th 2026
    Purchase End
    Present
    CJC-1295 (DAC)
    0 Records
    Product: CJC-1295 DAC 5mg
    Volume / Content
    6.04mg
    Lot Number
    538577 - Batch 1
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    October 12th 2025
    Purchase Start
    October 12th 2025
    Purchase End
    November 30th 2025
    Product: CJC-1295 DAC 5mg
    Volume / Content
    7.43mg
    Lot Number
    829471 - Batch 2
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    January 3rd 2026
    Product: CJC-1295 DAC 5mg
    Volume / Content
    6.95mg
    Lot Number
    1246331 - Batch 3
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 1st 2026
    Purchase Start
    February 2nd 2026
    Purchase End
    April 8th 2026
    Product: CJC-1295 DAC 5mg
    Current Lot
    Volume / Content
    5.16mg
    Lot Number
    OR-LPCJC5-426-B5
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    CJC-1295 / Ipamorelin
    0 Records
    Volume / Content
    10.30mg
    Lot Number
    395292 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    August 12th 2025
    Purchase Start
    August 12th 2025
    Purchase End
    September 1st 2025
    Volume / Content
    12.06mg
    Lot Number
    416313 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 2nd 2025
    Purchase Start
    October 2nd 2025
    Purchase End
    October 10th 2025
    Volume / Content
    11.8mg
    Lot Number
    727449 - Batch 3
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    November 7th 2026
    Purchase Start
    November 10th 2025
    Purchase End
    November 30th 2025
    Volume / Content
    11.35mg
    Lot Number
    853822 - Batch 4
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    December 26th 2025
    Volume / Content
    9.85mg
    Lot Number
    1136576 - Batch 5
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    January 9th 2026
    Purchase Start
    January 11th 2026
    Purchase End
    January 31st 2026
    Volume / Content
    10.76mg
    Lot Number
    1247385 - Batch 6
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 1st 2026
    Purchase Start
    February 2nd 2026
    Purchase End
    February 13th 2026
    Volume / Content
    10.42mg
    Lot Number
    1536499 - Batch 7
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 17th 2026
    Purchase Start
    February 19th 2026
    Purchase End
    March 28th
    Volume / Content
    22.34mg
    Lot Number
    1624882 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2026
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    March 30th 2026
    Volume / Content
    10.19mg
    Lot Number
    OR-LPCJCIPA10-326-B8
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    May 14th 2026
    Volume / Content
    20.47mg
    Lot Number
    OR-LPCJCIPA20-326-B2
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    Present
    Volume / Content
    10.20mg
    Lot Number
    OR-LPCJCIPA10-526-B9
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    June 8th 2026
    Volume / Content
    10.20mg
    Lot Number
    OR-LPCJCIPA10-526-B10
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    June 3rd 2026
    Purchase Start
    June 8th 2026
    Purchase End
    Present
    CJC-1295 (No DAC)
    0 Records
    Volume / Content
    5.21mg
    Lot Number
    395253 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    October 1st 2025
    Volume / Content
    5.79mg
    Lot Number
    416355 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 2nd 2025
    Purchase Start
    October 2nd 2025
    Purchase End
    December 9th 2025
    Volume / Content
    6.12mg
    Lot Number
    831643 - Batch 3
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    February 17th 2026
    Volume / Content
    5.63mg
    Lot Number
    1525387 - Batch 4
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 17th 2026
    Purchase Start
    February 19th 2026
    Purchase End
    May 18th 2026
    Current Lot
    Volume / Content
    5.19mg
    Lot Number
    OR-LP-CJCND5-526-B5
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    DSIP
    0 Records
    Product: DSIP 5mg
    Volume / Content
    5.19mg
    Lot Number
    1627401 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    May 12th 2026
    Product: DSIP 5mg
    Current Lot
    Volume / Content
    5.13mg
    Lot Number
    OR-LPDSP5-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Epithalon
    0 Records
    Volume / Content
    8.17mg
    Lot Number
    549788 - Batch 1
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 12th 2025
    Purchase Start
    October 13th 2025
    Purchase End
    December 21st 2025
    Volume / Content
    18.41mg
    Lot Number
    1485469 - Batch 1
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 11th 2026
    Purchase Start
    February 12th 2026
    Purchase End
    March 25th 2026
    Volume / Content
    10.14mg
    Lot Number
    OR-LPEPI10-326-B2
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 9th 2026
    Purchase End
    May 14th 2026
    Current Lot
    Volume / Content
    10.04mg
    Lot Number
    OR-LPEPI10-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    GHK-Cu
    0 Records
    Product: GHK‐Cu 50mg
    Volume / Content
    49.50mg
    Lot Number
    395291 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 12th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    October 19th 2025
    Product: GHK‐Cu 50mg
    Volume / Content
    48.18mg
    Lot Number
    416312 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    September 23rd 2025
    Purchase Start
    October 20th 2025
    Purchase End
    December 26th 2025
    Product: GHK‐Cu 50mg
    Volume / Content
    51.70mg
    Lot Number
    863901 - Batch 3
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 8th 2025
    Purchase Start
    December 26th 2025
    Purchase End
    February 4th 2026
    Product: GHK‐Cu 50mg
    Volume / Content
    51.04mg
    Lot Number
    1462133 - Batch 4
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    February 9th 2026
    Purchase End
    February 28th 2026
    Product: GHK‐Cu 50mg
    Volume / Content
    55.07mg
    Lot Number
    1623175 - Batch 5
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    April 17th 2026
    Product: GHK‐Cu 50mg
    Current Lot
    Volume / Content
    51.79mg
    Lot Number
    OR-LPGHK50-426-B6
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    GLOW
    0 Records
    Volume / Content
    96.13mg
    Lot Number
    416314 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 4th 2025
    Purchase Start
    October 5th 2025
    Purchase End
    November 27th 2025
    Volume / Content
    91.07mg
    Lot Number
    395293 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 12th 2025
    Purchase Start
    July 21st 2025
    Purchase End
    August 25 2025
    Volume / Content
    68.8mg
    Lot Number
    1321546 - Batch 1
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    January 12th 2026
    Purchase Start
    January 13th 2026
    Purchase End
    March 20th 2026
    Volume / Content
    81.19mg
    Lot Number
    OR-GLW-326-B4
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    March 21st 2026
    Purchase Start
    March 22nd 2026
    Purchase End
    April 27th 2026
    Volume / Content
    72.23mg
    Lot Number
    OR-LPGL70-426-B5
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    GLP-1R (Reta)
    0 Records
    Volume / Content
    5.96mg
    Lot Number
    427458 - Batch 1
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    October 2nd 2025
    Purchase Start
    October 4th 2025
    Purchase End
    February 8th 2026
    Volume / Content
    11.07mg
    Lot Number
    395237 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 7th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    October 8th 2025
    Volume / Content
    13.17mg
    Lot Number
    416347 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2026
    COA Date
    September 23rd 2025
    Purchase Start
    October 10th 2025
    Purchase End
    December 8th 2025
    Volume / Content
    12.53mg
    Lot Number
    817359 - Batch 3
    MFG Date
    November 2025
    EXP Date
    November 2026
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    January 27th 2026
    Volume / Content
    20.07mg
    Lot Number
    933107 - Batch 1
    MFG Date
    December 2025
    EXP Date
    December 2026
    COA Date
    December 19th 2025
    Purchase Start
    December 19th 2025
    Purchase End
    April 23rd 2026
    Volume / Content
    10mg
    Lot Number
    1316243 - Batch 4
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 3rd 2026
    Purchase Start
    February 4th 2026
    Purchase End
    March 9th 2026
    Volume / Content
    5.54mg
    Lot Number
    1473244 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    February 9th 2026
    Purchase End
    May 5th 2026
    Volume / Content
    10.88mg
    Lot Number
    1724211 - Batch 5
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    March 10th 2026
    Purchase Start
    March 11th 2026
    Purchase End
    May 5th 2026
    Volume / Content
    20.86mg
    Lot Number
    OR-LPGLPR10-326-B2
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 23rd 2026
    Purchase End
    June 1st 2026
    Current Lot
    Volume / Content
    10.26mg
    Lot Number
    OR-LPGLPR10-426-B6
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    Current Lot
    Volume / Content
    5.19mg
    Lot Number
    OR-LPGLPR5-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    GLP-1S (Sema)
    0 Records
    Current Lot
    Volume / Content
    5.45mg
    Lot Number
    395255 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    Present
    Volume / Content
    10.66mg
    Lot Number
    395224 - Batch 1
    MFG Date
    July 2025
    EXP Date
    July 2026
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    November 1st 2025
    Volume / Content
    13.99mg
    Lot Number
    877136 - Batch 2
    MFG Date
    November 2025
    EXP Date
    November 2026
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    April 9th 2026
    Current Lot
    Volume / Content
    10.33mg
    Lot Number
    OR-LPGLPS10-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    GLP-1T (Tirz)
    0 Records
    Volume / Content
    5.30mg
    Lot Number
    395255 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    May 5th 2026
    Volume / Content
    10.18mg
    Lot Number
    876254 - Batch 2
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    December 12th 2025
    Purchase Start
    January 13th 2025
    Purchase End
    April 7th 2026
    Volume / Content
    10.64mg
    Lot Number
    395236 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    January 12th 2025
    Current Lot
    Volume / Content
    10.23mg
    Lot Number
    OR-LPGLPT10-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    Current Lot
    Volume / Content
    5.31mg
    Lot Number
    OR-LPGLPT5-426-B2
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    Gut Matrix
    0 Records
    Volume / Content
    207.13mg
    Lot Number
    OR-CGMTX201-526-B1
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Ipamorelin
    0 Records
    Product: Ipamorelin 5mg
    Volume / Content
    5.47mg
    Lot Number
    395256 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    October 20th 2025
    Product: Ipamorelin 5mg
    Volume / Content
    6.09mg
    Lot Number
    416367 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    September 23rd 2025
    Purchase Start
    October 20th 2025
    Purchase End
    January 31st 2026
    Product: Ipamorelin 5mg
    Volume / Content
    5.01mg
    Lot Number
    1243137 - Batch 3
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 1st 2026
    Purchase Start
    February 2nd 2026
    Purchase End
    April 8th 2026
    Product: Ipamorelin 5mg
    Current Lot
    Volume / Content
    5.24mg
    Lot Number
    OR-LPIPA5-426-B4
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    Kisspeptin-10
    0 Records
    Current Lot
    Volume / Content
    4.78mg
    Lot Number
    359289 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 12th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    Present
    KLOW
    0 Records
    Volume / Content
    83.31mg
    Lot Number
    943117 - Batch 1
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 17th 2025
    Purchase Start
    December 17th 2025
    Purchase End
    March 26th 2026
    Volume / Content
    88.47mg
    Lot Number
    OR-LPKLO80-326-B2
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 1st 2026
    Purchase Start
    April 1st 2026
    Purchase End
    April 10th 2026
    Volume / Content
    83.34mg
    Lot Number
    OR-LPKLO80-326-B3
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    May 10th 2026
    Volume / Content
    82.46mg
    Lot Number
    OR-LPKLO80-526-B4
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    KPV
    0 Records
    Product: KPV 15mg
    Volume / Content
    15.96mg
    Lot Number
    793221 - Batch 1
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    November 15th 2025
    Purchase Start
    November 15th 2025
    Purchase End
    April 28th 2026
    Product: KPV 15mg
    Current Lot
    Volume / Content
    15.39mg
    Lot Number
    OR-LPKPV15-426-B2
    MFG Date
    April 2026
    EXP Date
    April 2026
    COA Date
    April 16th 2026
    Purchase Start
    April 29th 2026
    Purchase End
    Present
    Melanotan-2
    0 Records
    Product: Melanotan-2 10mg
    Volume / Content
    10.74mg
    Lot Number
    395221 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    September 15th 2025
    Product: Melanotan-2 10mg
    Volume / Content
    9.77mg
    Lot Number
    395362 - Batch 2
    MFG Date
    August 2025
    EXP Date
    August 2027
    COA Date
    August 23rd 2025
    Purchase Start
    September 16th 2025
    Purchase End
    November 27th 2025
    Product: Melanotan-2 10mg
    Volume / Content
    12.18mg
    Lot Number
    8714419 - Batch 3
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    December 12th 2025
    Purchase Start
    December 12th 2025
    Purchase End
    February 28th 2026
    Product: Melanotan-2 10mg
    Volume / Content
    9.88mg
    Lot Number
    1621439 - Batch 4
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 28th 2028
    Purchase Start
    February 28th 2028
    Purchase End
    March 30th 2026
    Product: Melanotan-2 10mg
    Current Lot
    Volume / Content
    10.18mg
    Lot Number
    OR-LPMT2-426-B5
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    MOTS-C
    0 Records
    Product: MOTS-C 10mg
    Volume / Content
    9.77mg
    Lot Number
    395233 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    September 30th 2025
    Product: MOTS-C 10mg
    Volume / Content
    11.68mg
    Lot Number
    855216 - Batch 3
    MFG Date
    November 2025
    EXP Date
    November 2026
    COA Date
    December 8th 2025
    Purchase Start
    December 9th 2025
    Purchase End
    January 10th 2026
    Product: MOTS-C 10mg
    Volume / Content
    9.63mg
    Lot Number
    416344 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 6th 2025
    Purchase Start
    October 6th 2025
    Purchase End
    November 21st 2025
    Product: MOTS-C 10mg
    Volume / Content
    10.84mg
    Lot Number
    1125231 - Batch 4
    MFG Date
    December 2025
    EXP Date
    December 2025
    COA Date
    January 9th 2026
    Purchase Start
    January 11th 2026
    Purchase End
    February 6th 2026
    Product: MOTS-C 10mg
    Volume / Content
    10.13mg
    Lot Number
    1244163 - Batch 5
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 1st 2026
    Purchase Start
    February 7th 2026
    Purchase End
    February 26th 2026
    Product: MOTS-C 10mg
    Volume / Content
    9.82mg
    Lot Number
    1622733 - Batch 6
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    April 4th 2026
    Product: MOTS-C 10mg
    Current Lot
    Volume / Content
    10.29mg
    Lot Number
    OR-LPMOTS10-426-B7
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    Product: MOTS-C 20mg
    Current Lot
    Volume / Content
    20.78mg
    Lot Number
    OR-LPMOTS20-426-B1
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 13th 2026
    Purchase Start
    May 14th 2026
    Purchase End
    Present
    NAD+
    0 Records
    Product: NAD+ 500mg
    Volume / Content
    549.12mg
    Lot Number
    398321 - Batch 1
    MFG Date
    August 2025
    EXP Date
    August 2027
    COA Date
    September 6th 2025
    Purchase Start
    September 15th 2025
    Purchase End
    November 19th 2025
    Product: NAD+ 500mg
    Volume / Content
    544.17mg
    Lot Number
    996575 - Batch 2
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    December 30th 2025
    Purchase Start
    December 30th 2025
    Purchase End
    February 2nd 2026
    Product: NAD+ 500mg
    Volume / Content
    499.44mg
    Lot Number
    1781124 - Batch 3
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    March 10th 2026
    Purchase Start
    March 11th 2026
    Purchase End
    April 30th 2026
    Pinealon
    0 Records
    Product: Pinealon 20mg
    Current Lot
    Volume / Content
    21.57mg
    Lot Number
    1746845 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    March 10th 2026
    Purchase Start
    March 11th 2026
    Purchase End
    Present
    PT-141
    0 Records
    Product: PT-141 10mg
    Volume / Content
    11.59mg
    Lot Number
    998557 - Batch 1
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    January 5th 2026
    Purchase Start
    January 6th 2026
    Purchase End
    March 1st 2026
    Product: PT-141 10mg
    Volume / Content
    10.30mg
    Lot Number
    1434582 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    March 1st 2026
    Purchase End
    April 30th 2026
    Product: PT-141 10mg
    Current Lot
    Volume / Content
    10.08mg
    Lot Number
    OR-LPPT10-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    Reconstitution Solution
    0 Records
    REGEN
    0 Records
    Volume / Content
    40.56mg
    Lot Number
    1513276 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 17th 2026
    Purchase Start
    February 19th 2026
    Purchase End
    June 6th 2026
    Volume / Content
    40.46mg
    Lot Number
    OR-LPREGEN40-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    June 3rd 2026
    Purchase Start
    June 6th 2026
    Purchase End
    Present
    Selank N-Acetyl Amidate
    0 Records
    Volume / Content
    9.51mg
    Lot Number
    1626694 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    May 21st 2026
    Current Lot
    Volume / Content
    10.19mg
    Lot Number
    OR-LPNASLK10-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Semax N-Acetyl Amidate
    0 Records
    Volume / Content
    29.12mg
    Lot Number
    1625200 - Batch 1
    MFG Date
    February 2026
    EXP Date
    February 2026
    COA Date
    February 28th 2026
    Purchase Start
    February 28th 2026
    Purchase End
    April 29th 2026
    Current Lot
    Volume / Content
    31.27mg
    Lot Number
    OR-LPNASMX30-526-B2
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Semax / Selank N-Acetyl
    0 Records
    Volume / Content
    15.97mg
    Lot Number
    983653 - Batch 1
    MFG Date
    December 2025
    EXP Date
    December 2027
    COA Date
    December 26th 2025
    Purchase Start
    December 26th 2025
    Purchase End
    April 6th 2026
    Volume / Content
    15.25mg
    Lot Number
    OR-LPNASML15-326-B2
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    March 31st
    Purchase Start
    April 6th 2026
    Purchase End
    Present
    Sermorelin
    0 Records
    Product: Sermorelin 5mg
    Volume / Content
    4.23mg
    Lot Number
    395297 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 12th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    October 10th 2025
    Product: Sermorelin 5mg
    Volume / Content
    5.04mg
    Lot Number
    416318 - Batch 2
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    September 23rd 2025
    Purchase Start
    October 10th 2025
    Purchase End
    February 1st 2026
    Product: Sermorelin 5mg
    Volume / Content
    5.90mg
    Lot Number
    1451922 - Batch 3
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    February 9th 2026
    Purchase End
    April 29th 2026
    Product: Sermorelin 5mg
    Current Lot
    Volume / Content
    5.20mg
    Lot Number
    OR-LPSERM5-426-B4
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 29th 2026
    Purchase End
    Present
    Sermorelin / Ipamorelin
    0 Records
    Volume / Content
    14.24mg
    Lot Number
    795263 - Batch 1
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    November 15th 2025
    Purchase Start
    November 15th 2025
    Purchase End
    January 22nd 2026
    Volume / Content
    9.67mg
    Lot Number
    1245860 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 1st 2026
    Purchase Start
    February 2nd 2026
    Purchase End
    April 21st 2026
    Volume / Content
    10.21mg
    Lot Number
    OR-LPSERMIPA10-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    SLU-PP-332 Capsules
    0 Records
    Current Lot
    Volume / Content
    1053.16mcg/Capsule
    Lot Number
    OR-CSLU1000-426-B1
    MFG Date
    April 2026
    EXP Date
    April 2027
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    SS-31, MOTS-C Blend
    0 Records
    Volume / Content
    20.40mg
    Lot Number
    OR-LPSSMC20-326-B1
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    April 26th 2026
    Volume / Content
    20.11mg
    Lot Number
    OR-LPSSMC20-526-B2
    MFG Date
    May 2026
    EXP Date
    May2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    TB-500
    0 Records
    Volume / Content
    5.54mg
    Lot Number
    395234 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 23rd 2025
    Purchase End
    November 21st 2025
    Current Lot
    Volume / Content
    6.24mg
    Lot Number
    825570 - Batch 2
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    November 28th 2025
    Purchase Start
    November 28th
    Purchase End
    Present
    Volume / Content
    9.94mg
    Lot Number
    427456 - Batch 1
    MFG Date
    September 2025
    EXP Date
    September 2027
    COA Date
    October 4th 2025
    Purchase Start
    October 6th 2025
    Purchase End
    January 13th 2026
    Volume / Content
    9.94mg
    Lot Number
    1356233 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    January 12th 2026
    Purchase Start
    January 13th 2026
    Purchase End
    April 9th 2026
    Current Lot
    Volume / Content
    10.22mg
    Lot Number
    OR-LPTB10-326-B5
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th
    Purchase End
    Present
    Tesamorelin
    0 Records
    Product: Tesamorelin 5mg
    Volume / Content
    5.76mg
    Lot Number
    395254 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 3rd 2025
    Purchase Start
    July 15th 2025
    Purchase End
    September 2nd 2025
    Product: Tesamorelin 5mg
    Volume / Content
    6.63mg
    Lot Number
    398321 - Batch 2
    MFG Date
    August 2025
    EXP Date
    August 2027
    COA Date
    September 15th 2025
    Purchase Start
    September 15th 2025
    Purchase End
    October 23rd 2025
    Product: Tesamorelin 5mg
    Volume / Content
    5.34mg
    Lot Number
    74659 - Batch 3
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    October 31st 2025
    Purchase Start
    October 31st 2025
    Purchase End
    January 29th 2026
    Product: Tesamorelin 5mg
    Volume / Content
    5.20mg
    Lot Number
    1449647 - Batch 4
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    February 9th 2026
    Purchase End
    March 13th 2026
    Product: Tesamorelin 5mg
    Volume / Content
    5.11mg
    Lot Number
    OR-LPTES5-326-B5
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    May 13th 2026
    Product: Tesamorelin 10mg
    Current Lot
    Volume / Content
    10.14mg
    Lot Number
    OR-LPTES10-426-B1
    MFG Date
    May 2026
    EXP Date
    May 20228
    COA Date
    May 2nd 2026
    Purchase Start
    May 14th 2026
    Purchase End
    Present
    Product: Tesamorelin 5mg
    Current Lot
    Volume / Content
    5.06mg
    Lot Number
    OR-LPTES5-526-B6
    MFG Date
    May 2026
    EXP Date
    May 2028
    COA Date
    May 18th 2026
    Purchase Start
    May 21st 2026
    Purchase End
    Present
    Tesamorelin / Ipamorelin
    0 Records
    Volume / Content
    20.34mg
    Lot Number
    776843 - Batch 1
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    November 7th 2025
    Purchase Start
    November 7th 2025
    Purchase End
    February 20th 2026
    Volume / Content
    21.02mg
    Lot Number
    1427354 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 9th 2026
    Purchase Start
    February 20th 2026
    Purchase End
    March 30th 2026
    Volume / Content
    20.39mg
    Lot Number
    OR-LPTESIPA20-426-B3
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    Present
    Testagen
    0 Records
    Product: Testagen 20mg
    Current Lot
    Volume / Content
    20.58mg
    Lot Number
    OR-LPTST20-426-B1
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    May 2nd 2026
    Purchase Start
    May 5th 2026
    Purchase End
    Present
    Thymosin Alpha-1
    0 Records
    Current Lot
    Volume / Content
    5.18mg
    Lot Number
    OR-LPTA5-326-B1
    MFG Date
    March 2026
    EXP Date
    March 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 10th 2026
    Purchase End
    Present
    Wolverine - BPC-157 / TB-500
    0 Records
    Volume / Content
    11.25mg
    Lot Number
    395253 - Batch 1
    MFG Date
    June 2025
    EXP Date
    June 2027
    COA Date
    July 4th 2025
    Purchase Start
    July 15th 2025
    Purchase End
    September 29th 2025
    Volume / Content
    11.17mg
    Lot Number
    817358 - Batch 2
    MFG Date
    November 2025
    EXP Date
    November 2027
    COA Date
    December 8th 2025
    Purchase Start
    December 8th 2025
    Purchase End
    December 31st 2025
    Volume / Content
    21.94mg
    Lot Number
    1248671 - Batch 2
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    January 13th 2026
    Purchase Start
    January 13th 2026
    Purchase End
    February 8th 2026
    Volume / Content
    20.19mg
    Lot Number
    527457 - Batch 1
    MFG Date
    October 2025
    EXP Date
    October 2027
    COA Date
    October 12th 2025
    Purchase Start
    October 13th 2025
    Purchase End
    November 18th 2025
    Volume / Content
    12.15mg
    Lot Number
    1338536 - Batch 3
    MFG Date
    January 2026
    EXP Date
    January 2028
    COA Date
    February 3rd 2026
    Purchase Start
    February 4th 2026
    Purchase End
    April 6th 2026
    Volume / Content
    21.98mg
    Lot Number
    1547512 - Batch 3
    MFG Date
    February 2026
    EXP Date
    February 2028
    COA Date
    February 17th 2026
    Purchase Start
    February 19th 2026
    Purchase End
    April 23rd 2026
    Volume / Content
    10.49mg
    Lot Number
    OR-LPBPCTB10-426-B4
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 16th 2026
    Purchase Start
    April 17th 2026
    Purchase End
    June 9th 2026
    Volume / Content
    20.32mg
    Lot Number
    OR-LPBPCTB20-326-B4
    MFG Date
    April 2026
    EXP Date
    April 2028
    COA Date
    April 9th 2026
    Purchase Start
    April 23rd 2026
    Purchase End
    Present
    Semax N-Acetyl Amidate 30mg - OROS Research

    Science Without Shortcuts™

    Founded in 2025, OROS Research was created with a singular mission: to bring integrity, transparency, and uncompromising quality to the research peptide industry. Born out of frustration with a market saturated by corner-cutting and profit-first mindsets, we set out to redefine what researchers should expect and deserve.

    At OROS, we formulate and finish our peptides in California in an ISO 5 Laminar Flow Facility following cGMP standards, ensuring every product meets the highest standards of purity, and precision. We don’t just claim quality, we prove it through rigorous testing and verifiable third-party COAs provided by licensed testing facilities in the U.S.

    Built by researchers, for researchers, we believe in doing things the right way. No shortcuts, no gray areas, and no false promises. Just high-purity, genuine USA-formulated peptides, reliable service, and a relentless focus on helping our research customers achieve meaningful results.

    Learn More

    Frequently Asked Questions

    Answers to our most common questions.

    What is OROS Reconstitution Solution intended for?

    OROS Reconstitution Solution is intended strictly for research use only. It is not intended for human or animal consumption, medical use, diagnostic use, cosmetic use, or injection.


    This product is a sterile, benzyl alcohol-preserved water solution designed for the reconstitution of lyophilized materials in a controlled research setting.

    What is in OROS Reconstitution Solution?

    OROS Reconstitution Solution is a sterile water-based solution preserved with 0.9% benzyl alcohol. Benzyl alcohol is included as a preservative to support the integrity of the solution after opening in appropriate research workflows.

    How is OROS Reconstitution Solution tested?

    Every batch is independently third-party tested in the United States for benzyl alcohol content, pH, endotoxins, microbial contamination, heavy metals, and multi-vial variance.


    This testing framework helps verify preservative content, solution consistency, cleanliness, contaminant control, and batch-to-batch uniformity before release.

    Why do you test for benzyl alcohol content?

    Benzyl alcohol content testing confirms the presence of benzyl alcohol and verifies that the solution meets its labeled 0.9% benzyl alcohol claim.


    This is an important quality-control step because preservative concentration can affect consistency and performance in research reconstitution workflows. We test to confirm the preservative level is aligned with the product specification before release.

    Why do you test pH?

    pH testing measures the acidity or alkalinity of the finished solution. This helps confirm that each batch is consistent with expected formulation specifications and supports batch-level quality control.


    Because Reconstitution Solution is used with lyophilized research materials, pH consistency is an important part of maintaining a controlled and predictable research preparation environment.

    What are endotoxins, and why test for them?

    Endotoxins are bacterial byproducts that may remain even when a solution appears clear and visually acceptable. Endotoxin testing helps provide additional insight into cleanliness and batch-level quality control.


    Because Reconstitution Solution is used to prepare lyophilized materials in a research setting, we believe endotoxin testing is an important part of verifying the quality and consistency of the finished solution.

    Why do you test for microbial contamination?

    Microbial testing helps verify that the finished solution meets microbiological quality expectations. This screening evaluates unwanted microbial presence that may indicate poor manufacturing, handling, packaging, or storage conditions.


    We believe microbial testing is essential for a sterile water-based solution because it helps confirm the product is manufactured and handled under controlled quality processes.

    Why do you test for heavy metals?

    Heavy metals such as lead, arsenic, cadmium, and mercury can be introduced through raw materials, water sources, equipment, or manufacturing environments.


    Heavy metal screening helps verify that elemental impurities remain within established specifications and supports overall contaminant control.

    What is multi-vial variance testing?

    Multi-vial variance testing evaluates multiple vials from the same batch to help confirm consistency across the lot.


    For Reconstitution Solution, this helps verify that finished vials are uniform in key quality attributes such as preservative content, pH, and overall batch consistency.

    Who performs your testing?

    As of April 2026, all new OROS Reconstitution Solution batches are tested by independent ISO/IEC 17025-accredited laboratories in the United States. ISO 17025 is an internationally recognized quality standard for testing and calibration laboratories that helps support analytical accuracy, method validation, reproducibility, traceability, and quality control.


    We believe utilizing accredited third-party laboratories provides an additional level of transparency and confidence in our testing program by ensuring analytical results are generated under established and independently audited quality systems.

    Where can I find the Certificate of Analysis (COA)?

    COA reports are available on each product page within the product image gallery. Current and previous batch information—including lot numbers, manufacturing dates, expiration dates, and testing documentation—can also be found on our Lab Results Page.

    Is this product made in the USA?

    OROS Reconstitution Solution is manufactured in the USA through qualified third-party manufacturing partners operating under controlled quality processes. All analytical testing is conducted in the United States by independent laboratories.


    What matters most is that finished batches undergo analytical verification before release, including preservative content, pH, endotoxins, microbial contamination, heavy metals, and multi-vial variance.

    How is it shipped?

    All orders are shipped from our North Carolina via UPS, with your choice of Ground, 2-Day, or Express services. Orders over $150 receive free UPS 2-Day shipping. Every order includes full shipment insurance at no additional cost.

    Do you ship with cold packs or temperature control?

    No. OROS Reconstitution Solution does not require cold-chain shipping or cold packs during standard transit windows.


    Short-term temperature fluctuations that may occur during normal shipping and final-mile delivery are not expected to compromise the product when it is stored properly after receipt.


    For best results, store the product according to the storage guidance listed on the label and avoid prolonged exposure to excessive heat, direct sunlight, or freezing conditions.

    Where do you ship?

    We currently ship to U.S. addresses only. We do not ship to PO Boxes, international destinations, military bases, or U.S. territories.

    What payment methods do you accept?

    We accept all major debit and credit cards, including American Express. HSAs and FSAs are not accepted.


    After checkout, you must complete our secure Payment Authorization Form. Orders are not processed or shipped until authorization is completed. This workflow ensures PCI compliance and protects your payment data.

    Do you accept returns?

    All sales are final. If an issue occurs with your order, please contact support@orosresearch.com within 7 days of delivery.

    How should this product be stored?

    Store Reconstitution Solution in a cool, dry environment away from direct sunlight, excessive heat, and freezing conditions. Keep the vial sealed until ready for use in a research setting.

    Looking for more answers?

    Visit our Full FAQ Page for detailed information on storage, COAs, policies, and additional support.